Skip to content


Jetrea (ocriplasmin) is an enzyme pharmaceutical. Ocriplasmin was first approved as Jetrea on 2013-03-13. It is used to treat retinal diseases in the USA. It has been approved in Europe to treat retinal diseases.
Trade Name Jetrea
Common Name Ocriplasmin
Indication retinal diseases
Drug Class Plasmin proteins and derivatives
Get full access now